There is increasing evidence that ivermectin, a drug usually used for head lice and other parasitic infections, may help COVID patients. A new randomized controlled trial from India found patients with mild to moderate COVID admitted to the hospital were more likely to survive.
Another study from Florida also showed lower mortality among patients given ivermectin, but others have shown no effect. There are also concerns about being able to safely get to the necessary blood levels of ivermectin in humans.
The investigation of this drug as a treatment is ongoing, and we cannot definitively say yet whether it works or not. But given its low cost and wide availability, it could be very helpful in the fight against COVID if it is found to be effective. Many trials are ongoing.